Publicacións en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (14)

2022

  1. Angioedema Due to Acquired Deficiency of C1-Inhibitor: A Cohort Study in Spain and a Comparison With Other Series

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 4, pp. 1020-1028

  2. Impact of house dust mite-driven asthma on children’s school performance and activity

    European Journal of Pediatrics, Vol. 181, Núm. 4, pp. 1567-1574

2020

  1. Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study

    AIDS Research and Therapy, Vol. 17, Núm. 1

2019

  1. Therapeutic potential of peptides from Ole e 1 in olive-pollen allergy

    Scientific Reports, Vol. 9, Núm. 1

2016

  1. Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients

    Journal of Aerosol Medicine and Pulmonary Drug Delivery, Vol. 29, Núm. 2, pp. 142-152

2014

  1. Diagnosis and allergen immunotherapy treatment of polysensitised patients with respiratory allergy in Spain: An Allergists' Consensus

    Clinical and Translational Allergy, Vol. 4, Núm. 1

  2. Management of angioedema without urticaria in the emergency department

    Annals of Medicine, Vol. 46, Núm. 8, pp. 607-618

2013

  1. Association of thromboxane A1 synthase (TBXAS1) gene polymorphism with acute urticaria induced by nonsteroidal anti-inflammatory drugs

    Journal of Allergy and Clinical Immunology, Vol. 132, Núm. 4, pp. 989-991

  2. Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes

    Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 9, pp. 1994-2002

  3. Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

    AIDS, Vol. 27, Núm. 1, pp. 81-85

2012

  1. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

    Retrovirology, Vol. 9

2011

  1. Safety evaluation of rapid build-up schedules with IR-standardized allergen extracts for subcutaneous immunotherapy of allergic respiratory diseases

    Expert Opinion on Drug Safety, Vol. 10, Núm. 6, pp. 947-955

1998

  1. Predictive factors influencing peak viral load drop in response to nucleoside reverse transcriptase inhibitors in antiretroviral-naive HIV-1-infected patients

    Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, Vol. 19, Núm. 1, pp. 55-60

1996

  1. A pilot case-control study of zidovudine compared with zidovudine plus didanosine in patients with advanced HIV-1 disease and no previous experience with antiretrovirals

    Antiviral Therapy, Vol. 1, Núm. 2, pp. 105-112